BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/20/2025 8:41:20 AM | Browse: 7 | Download: 0
 |
Received |
|
2025-04-08 15:20 |
|
Peer-Review Started |
|
2025-04-08 15:20 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2025-04-17 11:01 |
|
Revised |
|
2025-04-25 22:42 |
|
Second Decision |
|
2025-06-25 02:46 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2025-06-25 07:00 |
|
Articles in Press |
|
2025-06-25 07:00 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-08-07 02:40 |
|
Publish the Manuscript Online |
|
2025-08-20 08:41 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Neurosciences |
| Manuscript Type |
Minireviews |
| Article Title |
Glucose and antidiabetic therapy in temozolomide resistance in glioblastoma
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Emir Begagić, Amina Džidić-Krivić, Hakija Bečulić, Ragib Pugonja, Adnana Ljevaković, Binasa Bašić, Adem Nuhović, Elma Milanović, Semir Hadžić, Emir Bećirović, Lemana Buljubašić, Minela Bećirović and Mirza Pojskić |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Emir Begagić, Academic Editor, MD, Department of Neurosurgery, Cantonal Hospital Zenica, Crkvice 67, Zenica 72000, Bosnia and Herzegovina. begagicem@gmail.com |
| Key Words |
Drug resistance; Glioblastoma multiforme; Neoplasms; Glucose metabolism; Antidiabetic drugs |
| Core Tip |
Metformin shows promise as an adjunct therapy in glioblastoma by modulating glucose metabolism, enhancing temozolomide efficacy, and targeting glioma stem cells. Its ability to cross the blood-brain barrier and influence pathways such as AMPK and Wnt highlights its potential. However, its impact on survival remains unclear, requiring further clinical validation. |
| Publish Date |
2025-08-20 08:41 |
| Citation |
<p>Begagić E, Džidić-Krivić A, Bečulić H, Pugonja R, Ljevaković A, Bašić B, Nuhović A, Milanović E, Hadžić S, Bećirović E, Buljubašić L, Bećirović M, Pojskić M. Glucose and antidiabetic therapy in temozolomide resistance in glioblastoma. <i>World J Clin Oncol</i> 2025; 16(8): 108112</p> |
| URL |
https://www.wjgnet.com/2218-4333/full/v16/i8/108112.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v16.i8.108112 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
